Insulin aspart, recombinant Subcutaneous and Orthoclone OKT 3
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Orthovisc
- Insulin aspart, recombinant Subcutaneous-Orudis
- Insulin aspart, recombinant Subcutaneous-Orudis KT
- Insulin aspart, recombinant Subcutaneous-Oruvail
- Insulin aspart, recombinant Subcutaneous-Orvaten
- Insulin aspart, recombinant Subcutaneous-Os-Cal 500+D
- Orthoclone OKT 3-Insulin degludec
- Orthoclone OKT 3-Insulin Degludec (U-100) Prefilled Pens
- Orthoclone OKT 3-Insulin Degludec (U-100) Vials
- Orthoclone OKT 3-Insulin Degludec (U-200) Prefilled Pens
- Orthoclone OKT 3-Insulin degludec and liraglutide
- Orthoclone OKT 3-Insulin degludec and liraglutide Subcutaneous